abstract |
The present invention is directed to methods and compositions regarding delivery of adenoviral DNA in a liposomal formulation for disease treatment. In specific embodiments, the adenoviral DNA is circular and the liposomal formulation is comprised of DOTAP. In other specific embodiments, the disease being treated is cancer, such as lung cancer. |